KeyBank National Association’s Jazz Pharmaceuticals JAZZ Stock Holding History

KeyBank National Association’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.43M	Buy	10,084 +20	+0.2%	+$4.38K	0.01%	448
2026 Q1	$1.9M	Buy	10,064 +17	+0.2%	+$2.97K	0.01%	463
2025 Q4	$1.71M	Buy	10,047 +7	+0.1%	+$1.07K	0.01%	472
2025 Q3	$1.32M	Hold	10,040	–	–	﹤0.01%	529
2025 Q2	$1.07M	Hold	10,040	–	–	﹤0.01%	561
2025 Q1	$1.25M	Buy	10,040 +4	+0%	+$522	0.01%	508
2024 Q4	$1.24M	Hold	10,036	–	–	﹤0.01%	516
2024 Q3	$1.12M	Buy	10,036 +3	+0%	+$329	﹤0.01%	538
2024 Q2	$1.07M	Sell	10,033 -34	-0.3%	-$3.74K	﹤0.01%	521
2024 Q1	$1.21M	Sell	10,067 -736	-7%	-$90.2K	0.01%	490
2023 Q4	$1.33M	Buy	10,803 +731	+7%	+$91.2K	0.01%	455
2023 Q3	$1.3M	Sell	10,072 -18	-0.2%	-$2.4K	0.01%	423
2023 Q2	$1.25M	Buy	10,090 +18	+0.2%	+$2.42K	0.01%	443
2023 Q1	$1.47M	Hold	10,072	–	–	0.01%	413
2022 Q4	$1.6M	Sell	10,072 -6	-0.1%	-$879	0.01%	389
2022 Q3	$1.34M	Sell	10,078 -1	-0%	-$152	0.01%	404
2022 Q2	$1.57M	Buy	+10,079	New	+$1.55M	0.01%	391
2020 Q2	–	Sell	-2,262	Closed	-$226K	–	960
2020 Q1	$226K	Sell	2,262 -107	-5%	-$13.8K	﹤0.01%	829
2019 Q4	$354K	Buy	2,369 +42	+2%	+$5.71K	﹤0.01%	816
2019 Q3	$298K	Sell	2,327 -2,892	-55%	-$388K	﹤0.01%	840
2019 Q2	$744K	Sell	5,219 -4,049	-44%	-$544K	﹤0.01%	631
2019 Q1	$1.32M	Sell	9,268 -8,237	-47%	-$1.07M	0.01%	434
2018 Q4	$2.17M	Buy	17,505 +14,566	+496%	+$2.16M	0.01%	332
2018 Q3	$494K	Buy	2,939 +131	+5%	+$22.5K	﹤0.01%	768
2018 Q2	$484K	Buy	+2,808	New	+$459K	﹤0.01%	748

Other funds holding JAZZ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

KeyBank National Association's JAZZ Position: Q2 2026 in Review

KeyBank National Association increased its Jazz Pharmaceuticals (JAZZ) stake by 0.2% in Q2 2026, buying an estimated $4.38K and bringing the position to 10,084 shares worth $2.43M. The position accounts for 0.01% of the portfolio, ranked #448.

KeyBank National Association first reported a position in JAZZ in Q2 2018 and has held it in 25 quarters since. 641 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

KeyBank National Association held 10,084 shares of Jazz Pharmaceuticals worth $2.43M as of Q2 2026.
KeyBank National Association bought 20 Jazz Pharmaceuticals shares in Q2 2026, an estimated $4.38K.
Jazz Pharmaceuticals made up 0.01% of KeyBank National Association's portfolio in Q2 2026, its #448 holding.
KeyBank National Association first reported a position in Jazz Pharmaceuticals in Q2 2018 and has held it in 25 quarters since.
641 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on KeyBank National Association's 13F filing for Q2 2026, filed 28 Jul 2026.